JAYPIRKA Trademark

Trademark Overview


On Thursday, September 2, 2021, a trademark application was filed for JAYPIRKA with the United States Patent and Trademark Office. The USPTO has given the JAYPIRKA trademark a serial number of 97008373. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 18, 2023. This trademark is owned by Eli Lilly and Company. The JAYPIRKA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases
jaypirka

General Information


Serial Number97008373
Word MarkJAYPIRKA
Filing DateThursday, September 2, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 18, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 21, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases
Pseudo MarkJAY P IRK A

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, September 18, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 18, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 31, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 30, 2023SOU EXTENSION 1 GRANTED
Friday, January 13, 2023SOU EXTENSION 1 FILED
Monday, January 30, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 13, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 16, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 21, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 1, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 17, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 17, 2022ASSIGNED TO EXAMINER
Friday, October 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 6, 2021NEW APPLICATION ENTERED